Open access
101
Views
23
CrossRef citations to date
0
Altmetric
Review
Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date
Alberto GajofattoDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, ItalyCorrespondence[email protected]
Pages 3153-3157
|
Published online: 02 Nov 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.